You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
江蘇吳中(600200.SH)連續第二日漲停 正與相關醫院對接鹽酸阿比多爾片採購進院事宜
格隆匯 01-22 11:54
格隆匯1月22日丨繼昨日漲停後,江蘇吳中(600200.SH)今日再度漲停,報6.7元,漲停封單17.71萬手,暫成交5889萬元,最新總市值47.73億元。江蘇吳中昨日表示,在產在銷的鹽酸阿比多爾片為廣譜抗病毒藥物,該藥品除了抗流感病毒以外,對嚴重急性呼吸綜合徵SARS冠狀病毒和中東呼吸綜合徵MERS冠狀病毒有一定的療效。目前針對本次爆發的新型冠狀病毒疫情,已在積極與相關醫院對接鹽酸阿比多爾片採購進院事宜。不過,公司也同時表示,目前尚無證據表明該產品對新出現的“新型冠狀病毒”有療效。此外,公司昨晚還披露了業績預告,預計2019年度實現淨利6300萬元左右,上年同期虧損2.86億元。業績扭虧主要是轉讓子公司江蘇中吳置業股權預計增加淨利9000萬元左右;響水恆利達科技化工有限公司業績補償回購股份預計增加淨利潤5100萬元左右。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account